| |
| |
|
| Insider
Information: |
Ambrose Kristen |
| Relationship: |
SVP & Chief Accounting... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
7,500 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,981,100 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,500 |
|
|
| Total
Value |
$2,981,100 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
SVP & Chief Accounting... |
2024-04-02 |
7,500 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2024-04-02 |
4 |
AS |
$419.00 |
$100,560 |
D/D |
(240) |
7,500 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2024-04-01 |
4 |
D |
$418.10 |
$94,073 |
D/D |
(225) |
7,740 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2024-02-26 |
4 |
AS |
$425.70 |
$375,893 |
D/D |
(883) |
7,965 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2024-02-23 |
4 |
D |
$431.79 |
$357,522 |
D/D |
(828) |
8,848 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2024-02-12 |
4 |
AS |
$420.24 |
$577,410 |
D/D |
(1,374) |
9,676 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2024-02-09 |
4 |
D |
$422.74 |
$249,839 |
D/D |
(591) |
11,050 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,853 |
11,641 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,950 |
9,788 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2023-05-30 |
4 |
AS |
$329.82 |
$95,318 |
D/D |
(289) |
6,838 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2023-02-27 |
4 |
AS |
$287.25 |
$347,072 |
D/D |
(1,207) |
7,303 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2023-02-24 |
4 |
D |
$289.12 |
$145,138 |
D/D |
(502) |
8,510 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,516 |
9,012 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2022-04-25 |
4 |
AS |
$267.37 |
$88,143 |
D/D |
(327) |
3,496 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2022-04-01 |
4 |
D |
$263.09 |
$36,043 |
D/D |
(137) |
3,823 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,566 |
3,960 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2021-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,394 |
|
% |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
